Skip to main content

Table 1 Concentration of water-soluble and lipid metabolites as calculated from rat kidney tissue samples using 1 H-NMR

From: Effects of lovastatin treatment on the metabolic distributions in the Han:SPRD rat model of polycystic kidney disease

Metabolite

+/+

Cy/+

Cy/+ plus lovastatin

Acetate [nmol/g]

553.6 ± 288.8

229.7 ± 139.3*

272.2 ± 70.5

Alanine [nmol/g]

1309.8 ± 300.6

1117.2 ± 412.1

938.3 ± 324.4

Allantoin [nmol/g]

623.2 ± 237.7

1572.1 ± 257.1**

1150.1 ± 227.4*

Aspartate [nmol/g]

584.0 ± 98.2

381.1 ± 30.5*

572.7 ± 75.9**

Citrate [nmol/g]

1366.9 ± 296.8

919.3 ± 150.7*

1419.2 ± 92.2**

Glucose [nmol/g]

1145.5 ± 237.9

806.5 ± 113.2*

674.1 ± 104.6*

Glutamate [nmol/g]

4615.0 ± 461.6

3669.4 ± 806.1*

3690.8 ± 933.9

Glutamine [nmol/g]

1437.1 ± 724.0

1385.9 ± 303.4

1087.4 ± 425.7

Glycine [nmol/g]

4763.2 ± 2284.7

3173.1 ± 391.1

4999.2 ± 2408.0

GPC [nmol/g]

696.9.3 ± 48.2

541.8 ± 122.2*

631.3 ± 222.5

3-Hydroxybutyrate [nmol/g]

442.7 ± 118.8

301.2 ± 43.8*

335.4 ± 97.6

Lactate [nmol/g]

4480.7 ± 1303.0

4729.8 ± 696.7

5876.9 ± 393.5*

Myo-inositol [nmol/g]

8170.4 ± 1606.9

8789.3 ± 2184.8

9258.2 ± 2478.2

Succinate [nmol/g]

3353.4 ± 278.2

2219.6 ± 557.0**

2160.9 ± 420.3

Taurine [μmol/g]

12.0 ± 3.7

11.5 ± 1.6

11.7 ± 2.4

TAG/DAG [μmol/g]

8.5 ± 2.2

5.1 ± 0.8*

5.9 ± 2.2

Δ-2 PUFA [μmol/g]

12.1 ± 2.2

8.0 ± 0.7*

10.0 ± 2.4

Cholines [μmol/g]

1.8 ± 0.5

1.3 ± 0.1

1.6 ± 0.2*

  1. Values are presented as means ± standard deviations (n = 4-5). Significance levels are given for Cy/+ versus +/+ animals and Cy/+ plus lovastatin versus Cy/+ animals: *p < 0.05, **p < 0.01; as determined by ANOVA (with post-hoc pairwise multiple comparison Tukey-test). Abbreviations: DAG: diacylglycerol, GPC: glycerophosphocholine, PUFA: polyunsaturated fatty acids, TAG: triacylglycerol.